
Pattern recognition enhancement: Difference between revisions
>Graham Sources |
>Graham Trying better explanation |
||
Line 1: | Line 1: | ||
<onlyinclude> | <onlyinclude> | ||
[[File:Faceincloud.jpg|thumbnail|300px|'''Face in a cloud''' by '''[http://www.wired.co.uk/news/archive/2012-10/14/pareidolic-robot Neil Usher]''' - This image serves as an example of [[pattern recognition enhancement]].]] | [[File:Faceincloud.jpg|thumbnail|300px|'''Face in a cloud''' by '''[http://www.wired.co.uk/news/archive/2012-10/14/pareidolic-robot Neil Usher]''' - This image serves as an example of [[pattern recognition enhancement]].]] | ||
'''Pattern recognition enhancement''' can be described as an increase in a person's ability to recognise patterns (usually faces) within vague stimuli. Psychedelics enhance the availability of information managed in the brain through inhibiting the lower brain structures' gating systems.<ref name="Vollenweider1998">Recent advances and concepts in the search for biological correlates of hallucinogen-induced altered states of consciousness. Heffter Rev. Psychedel. Res. 1, 21–32. https://heffter.org/docs/hrireview/01/chapter3.pdf</ref><ref>Vollenweider F. (2001). Brain mechanisms of hallucinogens and entactogens. Dialogues Clin. Neurosci. 3, 265–279. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181663/</ref> | '''Pattern recognition enhancement''' can be described as an increase in a person's ability to recognise patterns (usually faces) within vague stimuli. Psychedelics enhance the availability of information managed in the brain through inhibiting the lower brain structures' gating systems.<ref name="Vollenweider1998">Recent advances and concepts in the search for biological correlates of hallucinogen-induced altered states of consciousness. Heffter Rev. Psychedel. Res. 1, 21–32. https://heffter.org/docs/hrireview/01/chapter3.pdf</ref><ref>Vollenweider F. (2001). Brain mechanisms of hallucinogens and entactogens. Dialogues Clin. Neurosci. 3, 265–279. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181663/</ref> General effects of psychedelics involve the temporary disruption of the normal neural hierarchy, replacing the normally predominant top-down control of information transfer in the brain with an increasingly bottom-up dynamic characterized by an increased influence of posterior regions over frontal areas of the brain. This decoupling of the frontal areas with the medial lobes resulted in a disorganization of the high-level networks responsible for large-scale brain network integrity, resulting in increased flexibility of networks and a more open communication among them. <ref>Riba, J., Rodrıguez-Fornells, A., Strassman, R. J., & Barbanoj, M. J. (2001). Psychometric assessment of the hallucinogen rating scale. Drug & Alcohol Dependence, 62(3), 215-223. https://doi.org/10.1016/S0376-8716(00)00175-7</ref><ref>Winkelman, M. J. (2017). The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology. Frontiers in Neuroscience, 11, 539. https://doi.org/10.3389/fnins.2017.00539</ref> | ||
This innate ability which human beings possess in everyday life is referred to by the scientific literature as pareidolia and is a well documented phenomenon.<ref>Liu, J., Li, J., Feng, L., Li, L., Tian, J., & Lee, K. (2014). Seeing Jesus in toast: neural and behavioral correlates of face pareidolia. Cortex, 53, 60-77. https://doi.org/10.1016/j.cortex.2014.01.013</ref><ref>Kato, M., & Mugitani, R. (2015). Pareidolia in infants. PloS one, 10(2), e0118539. https://doi.org/10.1371/journal.pone.0118539</ref><ref>Coolidge, F. L., & Coolidge, M. L. (2016, August 09). Why People See Faces When There Are None: Pareidolia. Retrieved February 21, 2018, from https://www.psychologytoday.com/blog/how-think-neandertal/201608/why-people-see-faces-when-there-are-none-pareidolia</ref> Common examples of this include spotting faces in everyday objects, such as the front of a car, or seeing different objects in clouds. | This innate ability which human beings possess in everyday life is referred to by the scientific literature as pareidolia and is a well documented phenomenon.<ref>Liu, J., Li, J., Feng, L., Li, L., Tian, J., & Lee, K. (2014). Seeing Jesus in toast: neural and behavioral correlates of face pareidolia. Cortex, 53, 60-77. https://doi.org/10.1016/j.cortex.2014.01.013</ref><ref>Kato, M., & Mugitani, R. (2015). Pareidolia in infants. PloS one, 10(2), e0118539. https://doi.org/10.1371/journal.pone.0118539</ref><ref>Coolidge, F. L., & Coolidge, M. L. (2016, August 09). Why People See Faces When There Are None: Pareidolia. Retrieved February 21, 2018, from https://www.psychologytoday.com/blog/how-think-neandertal/201608/why-people-see-faces-when-there-are-none-pareidolia</ref> Common examples of this include spotting faces in everyday objects, such as the front of a car, or seeing different objects in clouds. |
Revision as of 09:09, 21 February 2018

Pattern recognition enhancement can be described as an increase in a person's ability to recognise patterns (usually faces) within vague stimuli. Psychedelics enhance the availability of information managed in the brain through inhibiting the lower brain structures' gating systems.[1][2] General effects of psychedelics involve the temporary disruption of the normal neural hierarchy, replacing the normally predominant top-down control of information transfer in the brain with an increasingly bottom-up dynamic characterized by an increased influence of posterior regions over frontal areas of the brain. This decoupling of the frontal areas with the medial lobes resulted in a disorganization of the high-level networks responsible for large-scale brain network integrity, resulting in increased flexibility of networks and a more open communication among them. [3][4]
This innate ability which human beings possess in everyday life is referred to by the scientific literature as pareidolia and is a well documented phenomenon.[5][6][7] Common examples of this include spotting faces in everyday objects, such as the front of a car, or seeing different objects in clouds.
During this effect, pareidolia can become significantly more pronounced than it would usually be during everyday sober living. For example, scenery may look remarkably like detailed images, everyday objects may look like faces, and clouds may appear as fantastical objects, all without any visual alterations actually taking place. Once an image has been perceived within an object or landscape, the mind may further exaggerate this recognition through the hallucinatory effect known as transformations, which goes beyond pareidolia and becomes a standard visual hallucination.
Pattern recognition enhancement is often accompanied by other coinciding effects such as acuity enhancement and colour enhancement.[8][9] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline.
Image examples
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1B-LSD
- 1P-ETH-LAD
- 1P-LSD
- 1V-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 25B-NBOH
- 25B-NBOMe
- 25C-NBOH
- 25C-NBOMe
- 25D-NBOMe
- 25E-NBOH
- 25I-NBOH
- 25I-NBOMe
- 25N-NBOMe
- 2C-B
- 2C-B-FLY
- 2C-C
- 2C-D
- 2C-E
- 2C-I
- 2C-P
- 2C-T
- 2C-T-2
- 2C-T-21
- 2C-T-7
- 3-MMC
- 3C-E
- 3C-P
- 4-AcO-DET
- 4-AcO-DMT
- 4-AcO-MET
- 4-AcO-MiPT
- 4-FA
- 4-HO-DET
- 4-HO-DPT
- 4-HO-DiPT
- 4-HO-EPT
- 4-HO-MET
- 4-HO-MPT
- 4-HO-MiPT
- 5-MeO-DALT
- 5-MeO-DiBF
- 5-MeO-DiPT
- 5-MeO-MiPT
- 6-APB
- 6-APDB
- AL-LAD
- ALD-52
Psychoactive substances
Anecdotal reports which describe this effect within our experience index include:
- Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
- Experience: 200µg 1P-LSD (sublingual) + 12mg CBD - The Vortex of Empathy
- Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
- Experience: 25mg 2C-E (oral) - A mindblowing experience
- Experience: 80mg EPT - Slight improvement
- Experience:0.75g MDMA - Possibly some MDA through metabolisation?
- Experience:1000 Morning Glory seeds - Rediscovering the Self
- Experience:120µg LSD - First Bad Acid Trip, Psychosis
- Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
- Experience:2.5g Psilocybe Cubensis B+ strain - epiphany of nondualistic reality
- Experience:20mg (insufflated) - permanent all-encompassing states of unity and interconnectedness
- Experience:20mg - I looked up and saw an angry god-like figure made of clouds glaring down at me
- Experience:250 seeds - Harsh body load
- Experience:25mg - A labyrinth of organs and a storybook walk
- Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
- Experience:2mg 25C-NBOMe - Experimental trip to test personal limits of NBOMes
- Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
- Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
- Experience:300µg LSD - Togetherness and the Silent Dusk
- Experience:4-HO-DET (20 mg, oral) - Tripping for my birthday
- Experience:4.5g - The Grand Introduction to Beauty and Fear
- Experience:40mg - Brothermind and the Forest's Hand
- Experience:5g Mushrooms - Failed attempt at a Terence Mckenna style trip.
- Experience:BK-2C-B - Various experiences
- Experience:LSD (230 ug) - An amazing adventure by vikilikepsych
- Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
- Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
- Experience:Unknown dosage / 3 tabs - Ego death and a total break through in the snow
- Experience:~150mg MDA(oral) - a case of mistaken identity
See also
- Responsible use
- Subjective effects index
- Pattern recognition suppression
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
External links
References
- ↑ Recent advances and concepts in the search for biological correlates of hallucinogen-induced altered states of consciousness. Heffter Rev. Psychedel. Res. 1, 21–32. https://heffter.org/docs/hrireview/01/chapter3.pdf
- ↑ Vollenweider F. (2001). Brain mechanisms of hallucinogens and entactogens. Dialogues Clin. Neurosci. 3, 265–279. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181663/
- ↑ Riba, J., Rodrıguez-Fornells, A., Strassman, R. J., & Barbanoj, M. J. (2001). Psychometric assessment of the hallucinogen rating scale. Drug & Alcohol Dependence, 62(3), 215-223. https://doi.org/10.1016/S0376-8716(00)00175-7
- ↑ Winkelman, M. J. (2017). The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology. Frontiers in Neuroscience, 11, 539. https://doi.org/10.3389/fnins.2017.00539
- ↑ Liu, J., Li, J., Feng, L., Li, L., Tian, J., & Lee, K. (2014). Seeing Jesus in toast: neural and behavioral correlates of face pareidolia. Cortex, 53, 60-77. https://doi.org/10.1016/j.cortex.2014.01.013
- ↑ Kato, M., & Mugitani, R. (2015). Pareidolia in infants. PloS one, 10(2), e0118539. https://doi.org/10.1371/journal.pone.0118539
- ↑ Coolidge, F. L., & Coolidge, M. L. (2016, August 09). Why People See Faces When There Are None: Pareidolia. Retrieved February 21, 2018, from https://www.psychologytoday.com/blog/how-think-neandertal/201608/why-people-see-faces-when-there-are-none-pareidolia
- ↑ Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 4. https://doi.org/10.1007/s11419-014-0242-9
- ↑ Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., ... & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed Research International, 2014. https://dx.doi.org/10.1155%2F2014%2F734749